) [153]. This process is at present not scalable because it relies on highly-priced startup substrates which may be utilised to create psilocybin in less costly chemical synthesis methodologies. A methodology for de novo production of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae,The everyday urine drug screening for employment